Autres langues BioNTech SE

Actions

BNTX

US09075V1026

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 08/10/2026			Varia. 5j.	Varia. 1 janv.
92,06 ^USD	-3,35%		-4,95%	-3,30%

08/10	Les actions européennes cotées aux États-Unis sous forme d’ADR reculent jeudi	MT
08/10	BioNTech SE : Argus dégrade son opinion à neutre	ZM

Autres langues

08/10	European Equities Traded in US as ADRs Fall in Thursday Trading
07/10	Biontech Insider Sold Shares Worth $2,300,633, According to a Recent SEC Filing
06/10	Biontech Insider Sold Shares Worth $9,033,642, According to a Recent SEC Filing
02/10	Biontech Insider Sold Shares Worth $3,301,069, According to a Recent SEC Filing
02/10	Major drugmakers turn to China for licensing deals
01/10	European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
29/09	Summit Secures $2 Billion AstraZeneca Investment, Cancer Drug Trial Collaboration
28/09	Biontech Insider Sold Shares Worth $6,012,500, According to a Recent SEC Filing
28/09	BioNTech to Close 3 German Sites After Unsuccessful Sale Efforts
28/09	BioNTech to shutter three sites in Germany as no buyers emerge
28/09	BioNTech schließt drei deutsche Werke endgültig - Käufersuche gescheitert
28/09	Keine Käufer gefunden - drei Biontech-Werke machen dicht
28/09	Drei deutsche Biontech-Standorte werden geschlossen
25/09	European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week
24/09	PRESSESPIEGEL/Unternehmen
23/09	Neues Unternehmen von Biontech-Gründern heisst Arife
22/09	Biontech Insider Sold Shares Worth $7,860,757, According to a Recent SEC Filing
22/09	European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
21/09	European Equities Traded in the US as American depositary Receipts Rise in Monday Trading
18/09	Biontech Insider Sold Shares Worth $6,239,071, According to a Recent SEC Filing
18/09	European Equities Traded in the US as American Depositary Receipts Drop in Friday Trading
17/09	Pfizer Canada ULC And BioNTech SE Receive Health Canada Authorization For Omicron XFG-Adapted COMIRNATY COVID-19 Vaccine
17/09	Pfizer, BioNTech Secure Health Canada Authorization for Omicron XFG-Adapted COVID-19 Vaccine
17/09	Health Canada Authorizes Pfizer and BioNTech's Omicron XFG-Adapted COVID-19 Vaccine
16/09	Biontech Insider Sold Shares Worth $4,721,976, According to a Recent SEC Filing